Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study
出版年份 2023 全文链接
标题
Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study
作者
关键词
-
出版物
Diabetes Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-26
DOI
10.1007/s13300-023-01488-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus
- (2022) Tsung-Hui Wu et al. PLoS One
- Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
- (2022) Sok Cin Tye et al. Cardiovascular Diabetology
- The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents
- (2022) Panagiotis Theofilis et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effect of SGLT2 Inhibitors and Metformin on Inflammatory and Prognostic Biomarkers in Type 2 Diabetes Patients
- (2022) Xiaodong Zhang et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- The effect of sodium-glucose cotransporter 2 inhibitors on biomarkers of inflammation: A systematic review and meta-analysis of randomized controlled trials
- (2022) Dongmei Wang et al. Frontiers in Pharmacology
- Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial
- (2021) Taha Sen et al. DIABETOLOGIA
- Nephroprotection by SGLT2 Inhibition: Back to the Future?
- (2020) Luca De Nicola et al. Journal of Clinical Medicine
- Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial
- (2020) Megumi Oshima et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial
- (2020) Simke W. Waijer et al. Journal of the American Heart Association
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
- (2019) Hiddo J. L. Heerspink et al. DIABETOLOGIA
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
- (2019) Monika A. Niewczas et al. NATURE MEDICINE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease
- (2019) Yujing Zhou et al. ARCHIVES OF MEDICAL RESEARCH
- A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
- (2018) Susanne Eder et al. KIDNEY & BLOOD PRESSURE RESEARCH
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
- (2018) Michitsugu Kamezaki et al. Scientific Reports
- Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria
- (2018) Sharad Purohit et al. Frontiers in Immunology
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers
- (2016) H. J. L. Heerspink et al. DIABETES OBESITY & METABOLISM
- The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
- (2016) David Cherney et al. DIABETOLOGIA
- Reduction of a marker of oxidative stress with enhancement of iron utilization by erythropoiesis activation following epoetin beta pegol administration in iron-loaded db/db mice
- (2016) Mariko Noguchi-Sasaki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum and Urinary Progranulin in Diabetic Kidney Disease
- (2016) Bruna Bellincanta Nicoletto et al. PLoS One
- The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
- (2015) Volker Vallon Annual Review of Medicine
- Preface: evidence-based clinical practice guidelines for CKD—an abridged English version
- (2014) Kenjiro Kimura Clinical and Experimental Nephrology
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- GFR Estimation Using Standardized Serum Cystatin C in Japan
- (2012) Masaru Horio et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Tumor Necrosis Factor Receptors: Biology and Therapeutic Potential in Kidney Diseases
- (2012) Marijn M. Speeckaert et al. AMERICAN JOURNAL OF NEPHROLOGY
- The pathogenic role of the renal proximal tubular cell in diabetic nephropathy
- (2012) S. C. W. Tang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Clinical Significance of Urinary Liver-Type Fatty Acid-Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
- (2011) A. Kamijo-Ikemori et al. DIABETES CARE
- Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
- (2011) S. Katayama et al. DIABETOLOGIA
- The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice
- (2011) W. Tang et al. SCIENCE
- Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
- (2010) Sho-ichi Yamagishi et al. Oxidative Medicine and Cellular Longevity
- Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
- (2010) et al. Journal of Diabetes Investigation
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
- (2009) T. Ninomiya et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now